These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 24729390

  • 1. Association of DNA base excision repair genes (OGG1, APE1 and XRCC1) polymorphisms with outcome to platinum-based chemotherapy in advanced nonsmall-cell lung cancer patients.
    Peng Y, Li Z, Zhang S, Xiong Y, Cun Y, Qian C, Li M, Ren T, Xia L, Cheng Y, Wang D.
    Int J Cancer; 2014 Dec 01; 135(11):2687-96. PubMed ID: 24729390
    [Abstract] [Full Text] [Related]

  • 2. Clinical outcome of cisplatin-based chemotherapy is associated with the polymorphisms of GSTP1 and XRCC1 in advanced non-small cell lung cancer patients.
    Deng JH, Deng J, Shi DH, Ouyang XN, Niu PG.
    Clin Transl Oncol; 2015 Sep 01; 17(9):720-6. PubMed ID: 26033426
    [Abstract] [Full Text] [Related]

  • 3. Genetic polymorphism of DNA base-excision repair genes (APE1, OGG1 and XRCC1) and their correlation with risk of lung cancer in a Chinese population.
    Li Z, Guan W, Li MX, Zhong ZY, Qian CY, Yang XQ, Liao L, Li ZP, Wang D.
    Arch Med Res; 2011 Apr 01; 42(3):226-34. PubMed ID: 21722819
    [Abstract] [Full Text] [Related]

  • 4. Association of DNA base-excision repair XRCC1, OGG1 and APE1 gene polymorphisms with nasopharyngeal carcinoma susceptibility in a Chinese population.
    Li Q, Wang JM, Peng Y, Zhang SH, Ren T, Luo H, Cheng Y, Wang D.
    Asian Pac J Cancer Prev; 2013 Apr 01; 14(9):5145-51. PubMed ID: 24175791
    [Abstract] [Full Text] [Related]

  • 5. Single nucleotide polymorphisms of DNA base-excision repair genes (APE1, OGG1 and XRCC1) associated with breast cancer risk in a Chinese population.
    Luo H, Li Z, Qing Y, Zhang SH, Peng Y, Li Q, Wang D.
    Asian Pac J Cancer Prev; 2014 Apr 01; 15(3):1133-40. PubMed ID: 24606430
    [Abstract] [Full Text] [Related]

  • 6. Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer.
    Zhao W, Hu L, Xu J, Shen H, Hu Z, Ma H, Shu Y, Shao Y, Yin Y.
    Cancer Chemother Pharmacol; 2013 May 01; 71(5):1287-95. PubMed ID: 23479135
    [Abstract] [Full Text] [Related]

  • 7. Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum.
    Liao WY, Shih JY, Chang GC, Cheng YK, Yang JC, Chen YM, Yu CJ.
    J Thorac Oncol; 2012 Jun 01; 7(6):973-81. PubMed ID: 22551904
    [Abstract] [Full Text] [Related]

  • 8. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
    Han B, Guo Z, Ma Y, Kang S, Wang Y, Wei Q, Wu X.
    Int J Clin Exp Pathol; 2015 Jun 01; 8(4):4113-9. PubMed ID: 26097600
    [Abstract] [Full Text] [Related]

  • 9. Lack of any relationship between chemotherapy toxicity in non-small cell lung cancer cases and polymorphisms in XRCC1 codon 399 or XPD codon 751.
    Li Y, Huang XE, Jin GF, Shen HB, Xu L.
    Asian Pac J Cancer Prev; 2011 Jun 01; 12(3):739-42. PubMed ID: 21627375
    [Abstract] [Full Text] [Related]

  • 10. APE1 polymorphisms are associated with colorectal cancer susceptibility in Chinese Hans.
    Zhang SH, Wang LA, Li Z, Peng Y, Cun YP, Dai N, Cheng Y, Xiao H, Xiong YL, Wang D.
    World J Gastroenterol; 2014 Jul 14; 20(26):8700-8. PubMed ID: 25024628
    [Abstract] [Full Text] [Related]

  • 11. Genetic polymorphisms in DNA repair genes OGG1, APE1, XRCC1, and XPD and the risk of age-related cataract.
    Zhang Y, Zhang L, Song Z, Sun DL, Liu HR, Fu SB, Liu DR, Liu P.
    Ophthalmology; 2012 May 14; 119(5):900-6. PubMed ID: 22306120
    [Abstract] [Full Text] [Related]

  • 12. Effect of APE1 T2197G (Asp148Glu) polymorphism on APE1, XRCC1, PARP1 and OGG1 expression in patients with colorectal cancer.
    Santos JC, Funck A, Silva-Fernandes IJ, Rabenhorst SH, Martinez CA, Ribeiro ML.
    Int J Mol Sci; 2014 Sep 29; 15(10):17333-43. PubMed ID: 25268610
    [Abstract] [Full Text] [Related]

  • 13. Vitamin D receptor genetic variants are associated with chemotherapy response and prognosis in patients with advanced non-small-cell lung cancer.
    Xiong L, Cheng J, Gao J, Wang J, Liu X, Wang L.
    Clin Lung Cancer; 2013 Jul 29; 14(4):433-9. PubMed ID: 23522953
    [Abstract] [Full Text] [Related]

  • 14. Heterozygote advantage of methylenetetrahydrofolate reductase polymorphisms on clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy.
    Li X, Shao M, Wang S, Zhao X, Chen H, Qian J, Song X, Wang J, Jin L, Wu J, Li Q, Bai C, Han B, Gao Z, Lu D.
    Tumour Biol; 2014 Nov 29; 35(11):11159-70. PubMed ID: 25104092
    [Abstract] [Full Text] [Related]

  • 15. The impact of functional LIG4 polymorphism on platinum-based chemotherapy response and survival in non-small cell lung cancer.
    Jiang YH, Xu XL, Ruan HH, Xu WZ, Li D, Feng JG, Han QB, Mao WM.
    Med Oncol; 2014 May 29; 31(5):959. PubMed ID: 24722796
    [Abstract] [Full Text] [Related]

  • 16. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population.
    Xu JL, Wang ZW, Hu LM, Yin ZQ, Huang MD, Hu ZB, Shen HB, Shu YQ.
    Asian Pac J Cancer Prev; 2012 May 29; 13(5):2157-62. PubMed ID: 22901187
    [Abstract] [Full Text] [Related]

  • 17. Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients.
    Qian CY, Zheng Y, Wang Y, Chen J, Liu JY, Zhou HH, Yin JY, Liu ZQ.
    Chin J Cancer; 2016 Sep 02; 35(1):85. PubMed ID: 27590272
    [Abstract] [Full Text] [Related]

  • 18. Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum-paclitaxel chemotherapy.
    Li Z, Qing Y, Guan W, Li M, Peng Y, Zhang S, Xiong Y, Wang D.
    Cancer Chemother Pharmacol; 2014 Oct 02; 74(4):777-86. PubMed ID: 25107571
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of GSTP1, XRCC1 and XRCC3 polymorphisms in non-small cell lung cancer patients.
    Ke HG, Li J, Shen Y, You QS, Yan Y, Dong HX, Liu JH, Shen ZY.
    Asian Pac J Cancer Prev; 2012 Oct 02; 13(9):4413-6. PubMed ID: 23167352
    [Abstract] [Full Text] [Related]

  • 20. Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery.
    Santarpia M, Ramirez JL, de Aguirre I, Garrido P, Pérez Cano M, Queralt C, Gonzalez-Larriba JL, Insa A, Provencio M, Isla D, Camps C, Blanco R, Moran T, Rosell R, Spanish Lung Cancer Group.
    Clin Lung Cancer; 2017 Mar 02; 18(2):178-188.e4. PubMed ID: 27908619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.